Finance

Lists
2616:HKG
CStone Pharmaceuticals
HK$6.16
-0.16%
(-0.010) 1D
Sep 9, 4:08:04 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2616...
Open
HK$6.24
High
HK$6.30
Low
HK$6.00
Mkt. cap
9.84B
Avg. vol.
0.00
Volume
24.70M
52-wk high
HK$12.90
52-wk low
HK$4.01
EPS
-HK$0.33
No. of employees
102
Open
HK$6.24
High
HK$6.30
Low
HK$6.00
Mkt. cap
9.84B
Avg. vol.
0.00
Volume
24.70M
52-wk high
HK$12.90
52-wk low
HK$4.01
EPS
-HK$0.33
No. of employees
102
About CStone Pharmaceuticals
CEO-
Employees102
Founded2015
Headquarters-
SectorBiotechnology
Websitecstonepharma.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
110.07M
110.07M
102.55M
102.55M
Cost of goods sold
38.05M
38.05M
55.45M
55.45M
Cost of revenue
38.05M
38.05M
55.45M
55.45M
Research and development expenses
94.77M
94.77M
101.01M
101.01M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
46.58M
46.58M
62.22M
62.22M
Operating expense
141.35M
141.35M
163.22M
163.22M
Total operating expenses
179.40M
179.40M
218.67M
218.67M
Operating income
-69.33M
-69.33M
-116.12M
-116.12M
Other non operating income
3.45M
3.45M
3.30M
3.30M
EBT including unusual items
-76.88M
-76.88M
-126.14M
-126.14M
EBT excluding unusual items
-69.37M
-69.37M
-125.13M
-125.13M
Income tax expense
6.53M
6.53M
-
-
Effective tax rate
-8.50%
-8.50%
-
-
Other operating expenses
-
-
-
-
Net income
-83.41M
-83.41M
-126.14M
-126.14M
Net profit margin
-75.78%
-75.78%
-123.01%
-123.01%
Earnings per share
-
-
-
-
Interest and investment income
4.65M
4.65M
4.69M
4.69M
Interest expense
-3.18M
-3.18M
-2.56M
-2.56M
Net interest expenses
1.47M
1.47M
2.13M
2.13M
Depreciation and amortization charges
-
-
-
-
EBITDA
-66.41M
-66.41M
-113.13M
-113.13M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps